vTv Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
vTv Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • vTv Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $29M, a 18.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $29M +$4.59M +18.8% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $24.5M +$4.13M +20.3% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $20.3M +$2.91M +16.7% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $17.4M +$1.86M +12% Dec 31, 2020 10-K 2022-03-29
Q4 2019 $15.6M +$2.92M +23.1% Dec 31, 2019 10-K 2021-02-24
Q4 2018 $12.6M +$3.13M +33% Dec 31, 2018 10-K 2020-02-21
Q4 2017 $9.5M -$532K -5.3% Dec 31, 2017 10-K 2019-02-26
Q4 2016 $10M +$5.97M +147% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $4.06M Dec 31, 2015 10-K 2017-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.